Greg is a registered patent agent who focuses on patent counseling and prosecution in the chemical and life sciences. His technical experience spans small-molecule pharmaceuticals; oligonucleotide therapeutics (including nucleic acid analogues and antisense oligonucleotides (ASOs)); therapeutic peptides and peptidomimetics; and drug formulations. He also works with inventions in regenerative medicine, including stem cell-based technologies, as well as chemical and materials technologies, including inorganic materials and synthetic chemistry.

With training in biochemistry and organic synthesis, Greg helps translate complex R&D into clear, commercially focused patent positions. He supports clients with portfolio development, drafting, and prosecuting patent applications aligned to product and partnering objectives.

Greg also supports patent due diligence and patent searching and analysis, including patentability assessments, landscape analyses, and patent clearance/freedom-to-operate assessments.

He has supported patent portfolio development for companies in connection with significant partnering transactions and acquisitions, including matters involving early-stage collaborations and large-pharma buyouts.